Brown Advisory’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
3,242
+358
+12% +$165K ﹤0.01% 759
2026
Q1
$1.38M Sell
2,884
-422
-13% -$216K ﹤0.01% 763
2025
Q4
$1.86M Buy
3,306
+822
+33% +$467K ﹤0.01% 698
2025
Q3
$1.28M Sell
2,484
-22
-0.9% -$9.61K ﹤0.01% 759
2025
Q2
$787K Sell
2,506
-278
-10% -$83.5K ﹤0.01% 864
2025
Q1
$848K Sell
2,784
-5
-0.2% -$1.68K ﹤0.01% 822
2024
Q4
$927K Sell
2,789
-1
-0% -$339 ﹤0.01% 820
2024
Q3
$931K Buy
2,790
+740
+36% +$281K ﹤0.01% 801
2024
Q2
$844K Buy
2,050
+1,485
+263% +$588K ﹤0.01% 813
2024
Q1
$228K Buy
+565
New +$199K ﹤0.01% 1154
2019
Q2
Sell
-5,009
Closed -$296K 1178
2019
Q1
$296K Sell
5,009
-204
-4% -$12.2K ﹤0.01% 1125
2018
Q4
$276K Buy
+5,213
New +$286K ﹤0.01% 1096

Other funds holding MEDP

Brown Advisory's MEDP Position: Q2 2026 in Review

Brown Advisory increased its Medpace (MEDP) stake by 12% in Q2 2026, buying an estimated $165K and bringing the position to 3,242 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #759.

Brown Advisory first reported a position in MEDP in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.86M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Brown Advisory held 3,242 shares of Medpace worth $1.72M as of Q2 2026.
  • Brown Advisory bought 358 Medpace shares in Q2 2026, an estimated $165K.
  • Medpace made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #759 holding.
  • Brown Advisory first reported a position in Medpace in Q4 2018 and has held it in 12 quarters since.
  • Brown Advisory's Medpace position peaked at $1.86M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.